Patient Success Stories & Recovery Outcomes

Source: Guangzhou University of Chinese Medicine — Jinshazhou Hospital
Scope: Documented clinical outcomes across key oncological departments

---

📊 Performance Indicators

Metric	Result	Source
Annual Surgical Volume	35,000+	Hospital operational records
Annual Outpatients	1.2 million+	Hospital operational records

Note: These are operational figures, not clinical outcome rates. Specific success or survival rates by cancer type are not published in public registries, and individual results vary. Consult our MDT for a formal assessment of your case.

---

🔍 Factors Behind the Outcomes

• Precision That Spares Healthy Tissue: The hospital’s helical TomoTherapy system delivers highly targeted radiation designed to reduce radiation reactions and complications compared to conventional radiotherapy methods.
• Faster Healing Through Minimally Invasive Techniques: Heavy emphasis on minimally invasive interventions — including the NanoKnife, radiofrequency ablation, and Da Vinci robotic-assisted surgery — leads to shorter hospital stays and faster overall healing compared to conventional open procedures.
• Integrative Medicine Accelerating Recovery: Combining Western oncology with Traditional Chinese Medicine (TCM) is used specifically to accelerate functional recovery, mitigate toxic side effects of chemotherapy and radiation, and improve overall quality of life and immune resilience during treatment.
• High Procedural Volume Driving Experience: With 35,000+ surgeries performed annually, Jinshazhou Hospital’s surgical and oncology teams accumulate a level of procedural experience that contributes to clinical consistency.

---

The case summaries below are individual, documented examples shared for general information only. They are not typical or expected results, not a prediction of any outcome, and every patient’s situation is different. Consult the MDT for an assessment of your specific case.

🫁 Lung Cancer — Radiotherapy & Minimally Invasive Precision

• Tumour Cytoreduction (one case): A patient with advanced-stage lung cancer received a precise radiotherapy plan (TomoTherapy) tailored to their anatomical profile. Following two treatment cycles, clinical follow-up confirmed significant tumor shrinkage and the alleviation of chronic coughing symptoms.
• Symptom Improvement (one case): Under the clinical supervision of Dr. Wang, a patient showed tumour reduction within 30 days of targeted radiation, with documentation noting improved physical indicators and reduced localized pain.
• Interventional Recovery: Director Ma Xiaodong utilized minimally invasive targeted interventional therapy, resulting in minimal trauma and an accelerated recovery window compared to conventional open thoracic procedures.

---

肝 Liver Cancer — Interventional Radiology & Hyperthermia

• Functional Restoration: A patient who underwent interventional surgery for hepatocellular carcinoma exhibited a return of liver function enzymes (ALT/AST) to near-normal physiological ranges.
• Late-Stage Stabilization: For a case involving liver cancer with pulmonary metastasis, the Oncology Hyperthermia Center successfully managed the condition through Iodine-125 seed implantation and deep hyperthermia.
• Local Tumour Control: Professor Luo Pengfei’s interventional radiology protocols provided vital local tumour control for a patient with exhausted systemic options.

---

消化道 Gastrointestinal Cancer — Biomarker & Functional Recovery

• Biomarker Normalization: A gastric cancer patient treated by Professor Liu saw tumor markers (CEA) return to normal levels by early 2026. Side effects of post-operative chemotherapy were effectively managed via integrative supportive care.
• Interventional Management (one case): Director Hu Qunfeng performed Transarterial Chemoembolization (TACE) for gastric adenocarcinoma with liver metastasis. The procedure devascularized the lesions and supported the recovery of declining hepatic function.
• Rapid Post-Surgical Healing: A colorectal cancer patient achieved rapid healing post-resection, with both biochemistry indicators and tumor markers returning to baseline normal ranges.

---

🧬 Advanced Metastases & Complex Pathologies

• Breast Cancer (Bone/Lung Metastasis): Professor Hu Qunfeng’s team applied targeted minimally invasive ablation and hyperthermia for a patient with severe refractory pain, leading to significant quality-of-life improvements.
• Renal Cancer Management: A patient presenting with lung and liver metastases from renal cell carcinoma achieved clinical stabilization and minimal pain through precision minimally invasive techniques.
• Neurological Oncology (Glioma): Director Xu Xiaofeng combined CyberKnife M6 and molecular targeted therapy for a glioma patient, resulting in a stable condition and faster recovery than traditional craniotomy.
• Esophageal Surgery (one case): President Wang Yuandong utilized an original anastomosis technique for esophageal surgery, with a complication-free recovery and restored swallowing function reported in this case.
• Nasopharyngeal Carcinoma (NPC): High-precision radiotherapy protocols overseen by Professor Li Qun achieved effective local tumor control with significantly reduced mucosal toxicity.

---

Clinical outcomes are individualized and depend on specific pathology, stage, and patient comorbidities. Consult our Multidisciplinary Team (MDT) for a formal assessment.